Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 130, Issue 26
December 28 2017
Issue Cover

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Initial Hodgkin treatment of the frail elderly
Clinical Trials & Observations
David J. Straus
View Articletitled, Initial Hodgkin treatment of the frail elderly
INSIDE BLOOD COMMENTARY
DNA distress creates lethal opportunity in MPN
Jeffrey W. Tyner
View Articletitled, DNA distress creates lethal opportunity in MPN
INSIDE BLOOD COMMENTARY
VAMP-3 mediates platelet endocytosis
Charles J. Lowenstein
View Articletitled, VAMP-3 mediates platelet endocytosis

REVIEW ARTICLE

Platelet interaction with activated endothelium: mechanistic insights from microfluidics
Daniëlle M. Coenen,Tom G. Mastenbroek,Judith M. E. M. Cosemans
View Articletitled, Platelet interaction with activated endothelium: mechanistic insights from microfluidics
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL
Clinical Trials & Observations
Jonathan W. Friedberg,Andres Forero-Torres,Rodolfo E. Bordoni,Vivian J. M. Cline,Dipti Patel Donnelly,Patrick J. Flynn,Gregg Olsen,Robert Chen,Abraham Fong,Yinghui Wang,Christopher A. Yasenchak
View Articletitled, Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7+ normal lymphocytes
Tea Gogishvili,Sophia Danhof,Sabrina Prommersberger,Julian Rydzek,Martin Schreder,Christian Brede,Hermann Einsele,Michael Hudecek
View Articletitled, SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7<sup>+</sup> normal lymphocytes
Supplemental data

MYELOID NEOPLASIA

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms
Margaret Nieborowska-Skorska,Silvia Maifrede,Yashodhara Dasgupta,Katherine Sullivan,Sylwia Flis,Bac Viet Le,Martyna Solecka,Elizaveta A. Belyaeva,Lucia Kubovcakova,Morgan Nawrocki,Martin Kirschner,Huaqing Zhao,Josef T. Prchal,Katarzyna Piwocka,Alison R. Moliterno,Mariusz Wasik,Steffen Koschmieder,Tony R. Green,Radek C. Skoda,Tomasz Skorski
View Articletitled, Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms
Supplemental data
Immature CML cells implement a BMP autocrine loop to escape TKI treatment
Elodie Grockowiak,Bastien Laperrousaz,Sandrine Jeanpierre,Thibault Voeltzel,Boris Guyot,Stéphanie Gobert,Franck E. Nicolini,Véronique Maguer-Satta
View Articletitled, Immature CML cells implement a BMP autocrine loop to escape TKI treatment
Supplemental data

PLATELETS AND THROMBOPOIESIS

Cellubrevin/vesicle-associated membrane protein-3–mediated endocytosis and trafficking regulate platelet functions
Meenakshi Banerjee,Smita Joshi,Jinchao Zhang,Carole L. Moncman,Shilpi Yadav,Beth A. Bouchard,Brian Storrie,Sidney W. Whiteheart
View Articletitled, Cellubrevin/vesicle-associated membrane protein-3–mediated endocytosis and trafficking regulate platelet functions
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Extracellular histones induce erythrocyte fragility and anemia
Brief Report
Farzaneh Kordbacheh,Connor H. O’Meara,Lucy A. Coupland,Patrick M. Lelliott,Christopher R. Parish
View Articletitled, Extracellular histones induce erythrocyte fragility and anemia

TRANSPLANTATION

Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease
Kathy S. Wang,Haesook T. Kim,Sarah Nikiforow,Alexander T. Heubeck,Vincent T. Ho,John Koreth,Edwin P. Alyea,Philippe Armand,Bruce R. Blazar,Robert J. Soiffer,Joseph H. Antin,Corey S. Cutler,Jerome Ritz
View Articletitled, Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease
Supplemental data

LETTERS TO BLOOD

KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting
Maxime Battistella,Christophe Leboeuf,Caroline Ram-Wolff,Charlotte Hurabielle,Cécile Bonnafous,Hélène Sicard,Armand Bensussan,Martine Bagot,Anne Janin
View Articletitled, KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting
Supplemental data
Immunoglobulin G Fc glycans are not essential for antibody-mediated immune suppression to murine erythrocytes
Danielle Marjoram,Yoelys Cruz-Leal,Lidice Bernardo,Ngoc Phuong Lan Le,Max Crispin,Xiaojie Yu,Makoto Uchikawa,Alan H. Lazarus
View Articletitled, Immunoglobulin G Fc glycans are not essential for antibody-mediated immune suppression to murine erythrocytes
Supplemental data

BLOOD WORK

Rapidly fatal Klebsiella pneumoniae sepsis in a patient with pyruvate kinase deficiency and asplenia
Mohammad Faizan Zahid,Ashish Pal Singh Bains
View Articletitled, Rapidly fatal <em>Klebsiella pneumoniae</em> sepsis in a patient with pyruvate kinase deficiency and asplenia
All Issues

Advertisement

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis
How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction
How I manage major hemorrhage

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement